OMASPLEA Trademark

Trademark Overview

On Thursday, May 30, 2019, a trademark application was filed for OMASPLEA with the United States Patent and Trademark Office. The USPTO has given the OMASPLEA trademark a serial number of 88453583. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 3, 2023. This trademark is owned by Omeros Corporation. The OMASPLEA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders
omasplea

General Information

Serial Number88453583
Word MarkOMASPLEA
Filing DateThursday, May 30, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; biologics for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 14, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOmeros Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameOmeros Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events

Event DateEvent Description
Monday, July 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, December 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 1, 2022SOU EXTENSION 5 GRANTED
Friday, November 18, 2022SOU EXTENSION 5 FILED
Thursday, December 1, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 18, 2022TEAS EXTENSION RECEIVED
Thursday, May 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 24, 2022SOU EXTENSION 4 GRANTED
Tuesday, May 24, 2022SOU EXTENSION 4 FILED
Tuesday, May 24, 2022TEAS EXTENSION RECEIVED
Thursday, November 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 16, 2021SOU EXTENSION 3 GRANTED
Tuesday, November 16, 2021SOU EXTENSION 3 FILED
Tuesday, November 16, 2021TEAS EXTENSION RECEIVED
Saturday, May 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 13, 2021SOU EXTENSION 2 GRANTED
Thursday, May 13, 2021SOU EXTENSION 2 FILED
Thursday, May 13, 2021TEAS EXTENSION RECEIVED
Tuesday, November 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 13, 2020SOU EXTENSION 1 GRANTED
Friday, November 13, 2020SOU EXTENSION 1 FILED
Friday, November 13, 2020TEAS EXTENSION RECEIVED
Tuesday, June 2, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 18, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 25, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 28, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, August 28, 2019PRIORITY ACTION E-MAILED
Wednesday, August 28, 2019PRIORITY ACTION WRITTEN
Tuesday, August 20, 2019ASSIGNED TO EXAMINER
Friday, June 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 3, 2019NEW APPLICATION ENTERED

Related Keywords

omasplea disorders diseases neurological autoimmune hematological immunological disease inflammation injury related